BRENNEN

Industries / Health / Healthcare / Medical spas

Skin treatments

This work changes the outer layers of the skin without lasers: acids that peel them away, fine needles that make small wounds the skin repairs, and prescription creams that clinics sell for use at home.

7

Milestones achieved, from 1882 to 2025.

1

To watch for: announced, not yet confirmed outside.

3

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1882

    Peeling agents described

    A chemical peel puts an acid or similar chemical on the skin so that its top layers come away and new skin grows in their place. In Hamburg in 1882 the dermatologist Paul Gerson Unna described how salicylic acid, resorcinol, trichloroacetic acid (TCA) and phenol act on skin. By a 2012 review's account, phenol and TCA were in use at several centers through the first half of the 20th century, and alpha hydroxy acids (AHAs), the milder fruit and milk acids such as glycolic acid, joined them as surface peels in the late 1980s and 1990s.

    pmc.ncbi.nlm.nih.gov

    Credit

    Paul Gerson Unna

  2. 1979

    Fast phenol peels upset hearts

    E. S. Truppman and J. D. Ellenby watched the heart traces of 43 patients during phenol face peels. When half the face or more was peeled in under 30 minutes, irregular heartbeats were common; when the same was done over 60 minutes or more, none occurred. They advised heart monitoring and resuscitation equipment for every phenol peel, and a 2012 review gives the later practice of peeling the face one area at a time over 60 to 90 minutes.

    LessonA peel is a dose of chemical that enters the body, so the pace of application matters as well as the strength.

    ebi.ac.ukpmc.ncbi.nlm.nih.gov

    Credit

    E. S. Truppman and J. D. Ellenby

  3. 1988

    Tretinoin tested on sun damage

    Tretinoin is a prescription cream made from a form of vitamin A. In a 16-week double-blind trial, 30 patients put tretinoin on one forearm and a plain cream on the other; all improved on the tretinoin side only, and 14 of the 15 who used tretinoin on the face improved, against none of those given the plain cream. The FDA approved Renova, a 0.05% tretinoin cream, on 29 December 1995.

    LessonThe label kept the claim narrow: Renova's current label (0.02% strength) allows it only as an aid to "mitigation (palliation) of fine facial wrinkles" and says in capitals that it does not reverse photoaging.

    ebi.ac.ukapi.fda.govapi.fda.gov

    Credit

    J. S. Weiss, J. J. Voorhees and colleagues

  4. 1997

    Needles in place of lasers

    Desmond Fernandes began what he called percutaneous collagen induction in 1997: rolling a drum of fine needles over the skin to make many small punctures, so that the skin lays down new collagen while its surface stays intact, unlike laser resurfacing. A 2008 analysis by his group of 480 patients in South Africa and Germany reported a 40% thicker outer skin layer at one year in the 20 patients biopsied. Sources disagree on the start: a 2017 review traces the idea to "subcision" by Orentreich and Orentreich in 1995 and dates Fernandes's first product, the later Dermaroller, to 2006.

    ebi.ac.ukpmc.ncbi.nlm.nih.gov

    Credit

    Desmond Fernandes; Matthias Aust and colleagues

  5. 2005

    Acid products get sun warnings

    The FDA received 114 reports of skin harm from AHA products between 1992 and February 2004, most of them in 1994. Its own volunteer studies found that four weeks of a glycolic acid cream raised sensitivity to sunburn-type reddening by 18% and doubled UV damage to skin cells on average, with no difference left one week after stopping. In January 2005 it issued guidance asking that AHA cosmetics carry a "Sunburn Alert". The industry's Cosmetic Ingredient Review panel had already set limits: no more than 10% AHA at pH 3.5 or above for consumer products, and no more than 30% at pH 3.0 or above for salon products used by trained professionals.

    fda.govlibrary.scconline.org

    Credit

    US Food and Drug Administration; Cosmetic Ingredient Review Expert Panel

  6. 2018

    A microneedling pen authorized

    On 1 March 2018 the FDA granted Bellus Medical's request to market the SkinPen Precision System, a motorized pen with 14 needles, for facial acne scars in adults aged 22 or older, on prescription. The decision created a new device type, the microneedling device for aesthetic use, and its summary lists the maker's bench tests, such as needle depth accuracy at every setting. The trial behind it had 41 people complete it, only 20 of them with the final device, and tested depths up to 1.5 mm although the pen goes to 2.5 mm. In November 2020 the FDA set out in guidance when a microneedling product counts as a device, and by November 2026 the FDA's database listed 26 clearances of the type.

    accessdata.fda.govfda.govapi.fda.gov

    Credit

    US Food and Drug Administration; Bellus Medical

  7. 2025

    Warning on heated needles

    Radiofrequency (RF) microneedling sends electrical energy down the needles to heat small spots under the skin, and clinics use it for wrinkles and "tightening". On 15 October 2025 the FDA said it had reports of burns, scarring, fat loss, disfigurement and nerve damage from such uses, some needing surgical repair, and asked patients and providers to report injuries while it evaluated the devices with their makers.

    LessonA device cleared through the FDA's 510(k) route can be used in clinics for purposes its clearance did not test.

    fda.gov

    Credit

    US Food and Drug Administration

Watch for

  1. Exosomes after needling

    Exosomes are tiny packets released by cells, and clinics now rub preparations of them into freshly needled skin. In a randomized split-face trial in 60 adults, C. Yen, H. Huang and C. Lin report that the side given a topical exosome preparation after RF microneedling improved 3.32 points more on a wrinkle score at 12 weeks than the side given RF microneedling alone; the trial was not blinded and ran 12 weeks. An April 2026 systematic review found 8 usable studies of microneedling with exosomes, with 3 to 60 participants each, and said more evidence is needed on safety and effect. In May 2025 the FDA told a Houston seller that its stem-cell exosome gels were unapproved new drugs and unlicensed biological products.

    Achieved whena blinded trial against the same product without exosomes, run by researchers independent of the product's maker with at least six months of follow-up, confirms the benefit.

    ebi.ac.ukebi.ac.ukfda.gov

    Claimed by

    C. Yen, H. Huang and C. Lin, Journal of Craniofacial Surgery, August 2026

Open

  1. 01

    Peel strength, tested again

    A public lab survey of chemical peels on sale today, repeating the FDA's survey of 1999 and 2000: measure each product's acid content and pH and compare them with its label and with the Cosmetic Ingredient Review limits. Cover glycolic, lactic, salicylic and TCA peels, including the 30% to 70% peels marked for professional use. Products are bought and sent to a laboratory; nothing is put on anyone's skin.

    The brief
    Credit · unclaimed
  2. 02

    Needle pens on the bench

    An independent bench test of microneedling pens: how far the needles actually stick out at every depth setting, whether the stroke is steady, whether a used cartridge can be fitted again, and whether fluid gets past the cartridge into the handpiece. Test pens sold online for home use alongside cleared clinic models. Every test is on the bench, with a microscope camera, gel pads and dye; no skin is touched.

    The brief
    Credit · unclaimed
  3. 03

    What is in exosome serums

    Independent laboratory tests of skin products sold as containing exosomes: count and size the particles in each, check them for the surface proteins that mark exosomes (CD9, CD63 and CD81), and compare the results with label claims such as "billions of exosomes". Products are bought at retail and tested in the laboratory; nothing is applied to skin.

    The brief
    Credit · unclaimed

Open 01 · the brief

Peel strength, tested again

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public lab survey of chemical peels on sale today, repeating the FDA's survey of 1999 and 2000: measure each product's acid content and pH and compare them with its label and with the Cosmetic Ingredient Review limits. Cover glycolic, lactic, salicylic and TCA peels, including the 30% to 70% peels marked for professional use. Products are bought and sent to a laboratory; nothing is put on anyone's skin.

Why it is still open

The FDA's last published survey, reported by Jean Hubinger in 2002, tested 25 shop products bought in 1999 and 17 salon products collected by FDA inspectors in 2000. Two of the 17 salon products were below the recommended pH, none contained a sunscreen and only two advised sun protection. Products used only by professionals do not have to list their ingredients, the FDA says. A search found no later independent survey: a 1996 study by Becker and colleagues compared seven glycolic solutions for their effect on tissue, not against labels. The nearest recent work reads labels instead of testing products: a September 2026 audit of 31 glycolic acid brands sold on Amazon US, published on GitHub by the editor of a skincare site, found that 8 of the 26 whose pages could be read publish a numeric pH.

library.scconline.orgfda.govgithub.com

Built with what exists

A contract cosmetics laboratory running high-performance liquid chromatography (HPLC), the separation method the FDA survey used, or acid titration; a calibrated pH meter; a public spreadsheet with photos of each label and lot number.

  1. First step

    Buy ten glycolic acid peels sold online, five of them marked for professionals, and get quotes from two laboratories for acid content and pH.

  2. Done looks like

    At least 60 products from at least 10 brands, each with measured acid content, pH, label claim, lot and price, published with the method; 10 products retested by a second laboratory agree within 1 percentage point of acid and 0.2 pH units.

Open 02 · the brief

Needle pens on the bench

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

An independent bench test of microneedling pens: how far the needles actually stick out at every depth setting, whether the stroke is steady, whether a used cartridge can be fitted again, and whether fluid gets past the cartridge into the handpiece. Test pens sold online for home use alongside cleared clinic models. Every test is on the bench, with a microscope camera, gel pads and dye; no skin is touched.

Why it is still open

Depth tests for FDA review are run by each maker on its own pen; the SkinPen maker reported every setting within 0.25 mm short of the dial and never over. The one published outside measurement, by Gordon Sasaki in 2017, tested one clinic pen in skin removed during surgery: depths matched the settings up to 1.0 mm and were less consistent from 1.5 to 2.5 mm. EvenSkyn, a seller of home skin devices, says none of the 15 home devices it reviewed, its own included, publishes how deep its needles go.

accessdata.fda.govebi.ac.ukevenskyn.com

Built with what exists

A USB digital microscope with a calibration slide; Fiji (ImageJ) or OpenCV to measure needle length in the images; a phone camera at 240 frames per second to film the stroke; gelatin or silicone skin pads; food dye for the fluid test; the pass mark the FDA accepted for SkinPen (each setting within 0 to 0.25 mm short of the dial).

  1. First step

    Buy three pens sold online for home use and photograph the needle extension at each setting under a USB microscope.

  2. Done looks like

    At least 12 pens, each measured ten times at every setting, in a public table with pass or fail against that mark and the result of the fluid and cartridge tests; a second tester repeats three pens and agrees within 0.05 mm.

Open 03 · the brief

What is in exosome serums

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

Independent laboratory tests of skin products sold as containing exosomes: count and size the particles in each, check them for the surface proteins that mark exosomes (CD9, CD63 and CD81), and compare the results with label claims such as "billions of exosomes". Products are bought at retail and tested in the laboratory; nothing is applied to skin.

Why it is still open

Published work describes single products tested by their makers: Kadoya and colleagues (Dermatologic Surgery, 2025), most of them at Allergan Aesthetics, characterized one skin care product made from fibroblast culture medium and found 76 billion particles per milliliter, peaking at 150 nanometers, with the three marker proteins. The INKEY List, a brand that sells an exosome serum, says particle counts on labels tell buyers little. A search found no independent comparison of retail exosome products with their labels.

ebi.ac.uktheinkeylist.com

Built with what exists

Nanoparticle tracking analysis instruments such as Malvern Panalytical's NanoSight or Particle Metrix's ZetaView, at a university extracellular vesicle core facility; transmission electron microscopy; antibody tests for CD9, CD63 and CD81; the International Society for Extracellular Vesicles' MISEV2023 reporting guidelines (Journal of Extracellular Vesicles, 2024).

ebi.ac.uk

  1. First step

    Buy five exosome serums, record each label's claim, and ask two university core facilities for quotes.

  2. Done looks like

    At least 20 products from at least 12 brands, each with particle count, size distribution, marker results and the label claim, run with blank and base-cream controls; five products repeated at a second facility; methods reported to MISEV2023.